These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 11686430

  • 1. Genetically modified dendritic cell-based cancer vaccines.
    Bubeník J.
    Folia Biol (Praha); 2001; 47(5):153-5. PubMed ID: 11686430
    [No Abstract] [Full Text] [Related]

  • 2. DNA and RNA modified dendritic cell vaccines.
    Morse MA, Lyerly HK.
    World J Surg; 2002 Jul; 26(7):819-25. PubMed ID: 11948364
    [Abstract] [Full Text] [Related]

  • 3. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
    Castiglione F, Piccoli B.
    Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
    [Abstract] [Full Text] [Related]

  • 4. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 5. Generation of dendritic cell-based vaccines for cancer therapy.
    Reinhard G, Märten A, Kiske SM, Feil F, Bieber T, Schmidt-Wolf IG.
    Br J Cancer; 2002 May 20; 86(10):1529-33. PubMed ID: 12085199
    [Abstract] [Full Text] [Related]

  • 6. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun 20; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 7. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
    Breckpot K, Heirman C, Neyns B, Thielemans K.
    J Gene Med; 2004 Nov 20; 6(11):1175-88. PubMed ID: 15468193
    [Abstract] [Full Text] [Related]

  • 8. Priming anticancer active specific immunotherapy with dendritic cells.
    Mocellin S.
    Curr Opin Investig Drugs; 2005 Jun 20; 6(6):576-81. PubMed ID: 15988908
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cells: a journey from laboratory to clinic.
    Cerundolo V, Hermans IF, Salio M.
    Nat Immunol; 2004 Jan 20; 5(1):7-10. PubMed ID: 14699398
    [No Abstract] [Full Text] [Related]

  • 10. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
    Dullaers M, Thielemans K.
    J Gene Med; 2006 Jan 20; 8(1):3-17. PubMed ID: 16288497
    [Abstract] [Full Text] [Related]

  • 11. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.
    Vaccine; 2009 Mar 04; 27(10):1557-65. PubMed ID: 19171173
    [Abstract] [Full Text] [Related]

  • 12. Gene modification strategies to induce tumor immunity.
    Murphy A, Westwood JA, Teng MW, Moeller M, Darcy PK, Kershaw MH.
    Immunity; 2005 Apr 04; 22(4):403-14. PubMed ID: 15845446
    [Abstract] [Full Text] [Related]

  • 13. Cancer immunogene therapy.
    Yoshizawa H, Kagamu H, Gejyo F.
    Arch Immunol Ther Exp (Warsz); 2001 Apr 04; 49(5):337-43. PubMed ID: 11798131
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic vaccines for prostate cancer: a review of clinical data.
    Arlen PM, Gulley JL.
    Curr Opin Investig Drugs; 2005 Jun 04; 6(6):592-6. PubMed ID: 15988910
    [Abstract] [Full Text] [Related]

  • 15. [Dendrite cell-based cancer vaccines--clinical application].
    Svane IM, Berntsen A, Trepiakas R, Pedersen AE.
    Ugeskr Laeger; 2006 Apr 03; 168(14):1415-20. PubMed ID: 16584668
    [Abstract] [Full Text] [Related]

  • 16. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 03; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells and their role in cancer immunotherapy.
    Jalili A.
    Iran J Immunol; 2007 Sep 03; 4(3):127-44. PubMed ID: 17767012
    [Abstract] [Full Text] [Related]

  • 18. Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines.
    Jaffee EM, Pardoll DM.
    Methods; 1997 Jun 03; 12(2):143-53. PubMed ID: 9184378
    [Abstract] [Full Text] [Related]

  • 19. DC-based cancer vaccines: lessons from clinical trials.
    Brody JD, Engleman EG.
    Cytotherapy; 2004 Jun 03; 6(2):122-7. PubMed ID: 15203988
    [No Abstract] [Full Text] [Related]

  • 20. Cancer vaccines.
    Chekhun VF.
    Exp Oncol; 2008 Jun 03; 30(2):90. PubMed ID: 18680872
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.